BDBM800483 N-(3-((6-(4H- 1,2,4-triazol-4- yl)-1H-indazol-4- yl)amino)propyl)- 3-(((2-chloro-2''- (hydroxymethyl)- [1,1''-biphenyl]- 4-::N-(3-((6-(4H-1,2,4-triazol-4-yl)-1H-indazol-4-yl)amino)propyl)-3-(((2-chloro-2''-(hydroxymethyl)-[1,1''-biphenyl]-4-yl)methyl)amino)propanamide::US20260085062, Example 58

SMILES O=C(CCNCc1ccc(-c2ccccc2CO)c(Cl)c1)NCCCNc1cc(-n2cnnc2)cc2[nH]ncc12

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 800483   

TargetCasein kinase II subunit alpha(Human)
Cambridge Enterprise

US Patent
LigandChemical structure of BindingDB Monomer ID 800483BDBM800483(N-(3-((6-(4H- 1,2,4-triazol-4- yl)-1H-indazol-4- y...)
Affinity DataIC50: 0.280nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Cambridge Enterprise

US Patent
LigandChemical structure of BindingDB Monomer ID 800483BDBM800483(N-(3-((6-(4H- 1,2,4-triazol-4- yl)-1H-indazol-4- y...)
Affinity DataIC50: 40.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent